Navigation Links
MMD in Medical News

Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND

...ry may experience negative market trends, our continuing efforts to grow the business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, our common stock could be delisted from the Nasdaq Capital Market and other risks and challeng...

Toxic Strand Of RNA Causes Myotonic Muscular dystrophy

...hopes the research might lead to new therapies for mmd in the next few years. "If we develop a therapy to...icroscope. They also integrated an "on switch" for mmd in the mice, activated by giving them doxycycline,...TG repeats, they developed the hallmarks of type 1 mmd within a few weeks, including an inability to rela...
MMD in Medical Technology

Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs

... by Year-End - Enrollment On Track in mmd Clinical Study - ALS Expanded Access Pro...ehrig's disease. A Phase 2 trial of IPLEX(TM) in mmd is on-going and a substantial portion of the exter...e Muscular Dystrophy Association in late 2007. mmd Phase 2 trial at-a-glance: -- All sites have been...

Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy

...lopment, and maximize the market opportunities for mmd available to us." Orphan status is granted by th... years of market exclusivity upon approval for the mmd indication. In addition, Insmed is eligible for ta...e drug candidate through the regulatory process. mmd affects approximately 37,000 Americans, and nearly...
MMD in Biological News

American Chemical Society's Weekly PressPac -- Nov. 19, 2008

...most common form of muscular dystrophy in adults. mmd affects about 1 in 8,000 people. Their findings a...udy, Benjamin Miller and colleagues point out that mmd differs from typical hereditary diseases. They re...tivity and cause symptoms of the disease. Rather, mmd is caused by wayward or "toxic" strands of RNA. ...

Toxic molecule may cause most common type of muscular dystrophy

...sulin resistance. Many people don't know they have mmd until their teens or twenties. To prove the...hopes the research might lead to new therapies for mmd in the next few years. "If we develop a therapy to...croscope. They also integrated an "on switch" for mmd in the mice, activated by giving them doxycycline,...
MMD in Biological Technology

Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

...tial Initiation of Phase II Trial for IPLEX(TM) in mmd Patients with Severe Insulin Resistance - RIC...s of testosterone. The drug was well tolerated in mmd subjects and demonstrated a safety profile consist...ional Phase II trial focused solely on a subset of mmd patients with severe insulin resistance who, based...

Insmed CEO Resigns Due to Health Concerns

...ry may experience negative market trends, our continuing efforts to grow the business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, we may lack financial resources to complete development of product candidates and other risks...

Insmed Announces First Quarter 2009 Financial Results

...orward on all fronts. We continue to expect preliminary Phase 2 results in mmd before the end of the second quarter. In addition, the ALS EAP is set to e...e business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, we may lack financi...

Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule

...ry may experience negative market trends, our continuing efforts to grow the business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, our common stock could be delisted from the Nasdaq Capital Market and other risks and challeng...

Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results

...ted an external assessment of the total market for mmd treatments that indicated that the market for mmd could be as high as between $800 million and $1.4 ...tinue moving ahead with our IPLEX(TM) programs for mmd and ALS. In addition, we intend to pursue a compr...

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008

...ivity in the current quarter compared to last year as our phase 2 IPLEX(TM) mmd trial continues to progress. SG&A Expenses were consistent quarter over qua....0 million from the Muscular Dystrophy Association supporting the IPLEX(TM) mmd trial. This was partially offset by the absence of license income from Napo...

Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants

...d States in December 2005 for the treatment of children with growth failure due to severe primary IGF-I deficiency, is currently being investigated in mmd and ALS. About ROP ROP is a disease of the eye that affects prematurely born babies. It is thought to be caused by disorganised growth of retinal ...

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008

...ategic financial options will ensure that we make informed decisions for moving our FOB program forward, and advancing the development of IPLEX(TM) in mmd and ALS." Revenues for the second quarter ended June 30, 2008 were $2.6 million, up from $2.3 million for the corresponding period in 2007. The incr...

Insmed Announces First Quarter 2008 Financial Results

...llan, President and CEO of Insmed. "We are aggressively pursuing a partner for our FOB program and continue to advance the development of IPLEX(TM) in mmd and ALS." Revenues for the first quarter ended March 31, 2008 were $2.3 million, up from $1.7 million for the corresponding period in 2007. The incr...

Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results

... portion of the external costs associated with the mmd trial; -- Granted Orphan Drug designation for IPLEX(TM) for the treatment of mmd by the FDA, providing the Company with, among othe...sivity upon approval of IPLEX(TM) for the mmd indication; and -- Completed an external ass...
Other Tags
(Date:7/26/2014)... According to the Tinnitus ... this is a comprehensive guide that consists ... all types of disorders related to ... due to Ménière's disease ,     Objective ... tinnitus ,     Inner, middle or external ...
(Date:7/26/2014)... The U.S. Food & Drug Administration (FDA) has ... medication guide for AndroGel to include blood clots in the ... topical low testosterone medication, notes Wright & Schulte LLC. ... the low testosterone theapy drug, has also updated the official ... as signs of a blood clot in the leg and ...
(Date:7/26/2014)... July 26, 2014 According to the ... Vkool.com, this is a comprehensive guide that provides readers ... tattoos . This book also teaches them how to ... medical procedures in their own home for drastic results. ... Rid Tattoo Naturally" book includes step-by-step tutorials and product ...
(Date:7/25/2014)... 26, 2014 2014 Deep ... Permeation Chromatography Industry” is a professional and ... China Gel Permeation Chromatography market. The report ... Gel Permeation Chromatography definition, classification, application, and ... overview. This research covers the international market ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 A federal ... judgment in two DePuy Pinnacle hip lawsuits ( http://www.depuypinnacle-lawsuit.com/ ... for the claims to go before a jury on ... opinion rendered on July 18th, U.S. District Judge Ed ... the two Plaintiffs’ claims may proceed to trial against ...
Breaking Medicine News(10 mins):Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 2Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 3Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 4Health News:FDA Updates AndroGel Risks to Include Blood Clots In Legs and Lungs as Testosterone Treatment Lawsuits Move Forward 5Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4
(Date:7/25/2014)... Ravi Birla, associate professor of biomedical engineering at ... textbook on tissue engineering and artificial organ development., ... a comprehensive guide to entering into the field ... and professor of biomedical engineering at UH, served ... said that while there are other published books ...
(Date:7/25/2014)... at the University of Adelaide has opened the way for ... powdery mildew. , In Australia, annual barley production is second ... mildew is one of the most important diseases of barley. ... discovered the composition of special growths on the cell walls ... into the leaf. , The research, by the ARC Centre ...
(Date:7/25/2014)... complex congenital central nervous system disease that is ... tubes during the embryonic phase. Many patients have ... and neurocognitive retardation. Such problems decrease the patients, ... at Ankara Physical Medicine and Rehabilitation Education and ... children with SB, using the Pediatric Evaluation of ...
Breaking Biology News(10 mins):University of Houston researcher publishes textbook on tissue engineering 2New hope for powdery mildew resistant barley 2
Other Contents